Aspergillosis

Equine Infectious Diseases

Volumn , Issue , 2007, Pages 419-431

  Kohn, Catherine ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349623347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2406-4.50061-2     Document Type: Chapter

References (137)

1. Gugnani HC Ecology and taxonomy of pathogenic aspergilli. Frontiers Biosci 2003, 8:s346.
2. Picard JA, Vismer HF Mycoses. Infectious diseases of livestock 2004, 2095. Oxford University Press, Cape Town. J.A. Coetzer, R.C. Tustin (Eds.).
3. Carrasco L, Tarradas MC, Gomez-Villamandos, et al. Equine pulmonary mycosis due to Aspergillus niger and Rhizopus stolonifer. J Comp Pathol 1997, 117:191.
4. Tunev SS, Ehrhart EJ, Jensen HE, et al. Necrotizing mycotic vasculitis with cerebral infarction caused by Aspergillus niger in a horse with acute typhlocolitis. Vet Pathol 1999, 36:347.
5. Keegan KG, Dillavou CL, Tornquist SE, et al. Subcutaneous mycetoma-like granuloma in a horse caused by Aspergillus versicolor. J Vet Diagn Invest 1995, 7:564.
6. Marolt J, Naglic T, Hajsig D Aspergillus oryzae as a cause of keratomycosis in the horse. Tierarztl Prax 1984, 12(4):489.
7. Hintz HF Molds, mycotoxins, and mycotoxicosis. Vet Clin North Am Equine Pract 1990, 6(2):419.
8. Rementeria A, Lopez-Molina N, Ludwig A, et al. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 2005, 22:1.
9. Tekaia F, Latge JP Aspergillus fumigatus, saprophyte or pathogen?. Curr Opin Microbiol 2005, 8:385.
10. Krappmann S, Braus GH Nitrogen metabolism of Aspergillus and its role in pathogenicity. Med Mycol 2005, 43(suppl 1):s31.
11. McGorum BC, Dixon PM, Halliwell RE Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Vet J 1993, 25(4):261.
12. Tomee JF, Kauffman FH Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000, 30:476.
13. Nardoni S, Mancianti F, Sgorbini M, et al. Evaluation of seasonal presence of fungal spores in three stables. Ippologia 2003, 14(1):61.
14. Moore CP, Heller BS, Marjors LF, et al. Prevalence of microorganisms in hospitalized and stabled horses. Am J Vet Res 1988, 49(6):773.
15. Whiteley RK, Moore CP Microbiology of the equine eye in health and disease. Vet Clin North Am Large Animal Pract 1984, 6(3):451.
16. Riis RC Equine ophthalmology. Textbook of veterinary ophthalmology 1981, 569. Lea & Febiger, Philadelphia. K. Gelatt (Ed.).
17. McLaughlin SA, Gilger BC, Whitely RD Infectious keratitis in horses: evaluation and management. Compend Equine Pract 1992, 14(3):372.
18. Rosa M, Cardozo LM, Da Sliva Pereira J, et al. Fungal flora of normal eyes of healthy horses for the States of Rio de Janeiro, Brazil. Vet Ophthalmol 2003, 6(1):51.
19. Samuelson DA, Andersen BS, Gwin RM Conjunctival fungal flora in horses, cattle, dogs, and cats. J Am Vet Med Assoc 1984, 184(10):1240.
20. Coad CT, Robinson NM, Wilhelmus KR Antifungal sensitivity testing for equine keratomycosis. Am J Vet Res 1985, 46(3):676.
21. Beech J Cytology of tracheobronchial aspirates in horses. Vet Pathol 1975, 12:157.
22. Slocombe RF, Slauson DO Invasive pulmonary aspergillosis of horses: an association with acute enteritis. Vet Pathol 1988, 25:277.
23. Dascanio JJ, Schweizer C, Ley WB Equine fungal endometritis. Equine Vet Educ 2001, 3(6):420.
24. Nasisse MP, Nelms S Equine ulcerative keratitis. Vet Clin North Am Equine Pract 1992, 8(3):537.
25. Gaarder JE, Rebhun WC, Ball MA, et al. Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal with fungal keratitis: 53 cases (1978-1996). J Am Vet Med Assoc 1998, 213(1):105.
26. Andrew SE, Brooks DE, Smith PJ, et al. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987-1996). Equine Vet J 1998, 30(2):109.
27. Moore CP, Collins BK, Fales WH Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986-1994). J Am Vet Med Assoc 1995, 207(7):928.
28. Brooks DE, Andrew SE, Dillavou Cl, et al. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Am J Vet Res 1998, 59(2):138.
29. Sansom J, Featherstone H, Barnett KC Keratomycosis in six horses in the United Kingdom. Vet Rec 2005, 156:13.
30. Pugh DG, Bowen JM, Kloppe LH Fungal endometritis in mares. Compend Contin Educ 1986, 8(4):S173.
31. Osweiler GD Toxicology 1996, 416. Williams & Wilkins, Philadelphia.
32. Morrison CJ, Lindsley MD Serological approaches to the diagnosis of invasive fungal infections. Fungal pathogenesis: principles and clinical applications 2002, 671. Marcel Dekker, New York. R.A. Calderone, R.L. Cihlar (Eds.).
33. Carrasco L, Mendez A, Jensen HE Chronic bronchopulmonary aspergillosis in a horse with Cushing's syndrome. Mycoses 1996, 39:443.
34. Sweeney CR, Habecker PL Pulmonary aspergillosis in horses: 29 cases (1974-1997). J Am Vet Med Assoc 1999, 214(6):808.
35. Buechner-Maxwell V, Zhang C, et al. Intravascular leukostasis and systemic aspergillosis in a horse with subleukemic acute myelomonocytic leukemia. J Vet Intern Med 1994, 8(4):258.
36. Blue J, Perdrizet J, Brown E Pulmonary aspergillosis in a horse with myelomonocytic leukemia. J Am Vet Med Assoc 1987, 190(12):1562.
37. Hattel AL, Drake TR, Anderholm BJ, et al. Pulmonary aspergillosis associated with acute enteritis in a horse. J Am Vet Med Assoc 1991, 199(5):589.
38. Pace LW, Wirth NR, Foss RR, et al. Endocarditis and pulmonary aspergillosis in a horse. J Vet Diagn Invest 1994, 6(4):504.
39. Green SL, Hager DA, Calderwood Mays MD, et al. Acute diffuse mycotic pneumonia in a 7-month-old colt. Vet Radiol 1987, 28(6):216.
40. Blomme E, Del Piero F, La Perle KM, et al. Aspergillosis in horses: a review. Equine Vet Educ 1998, 10:86.
41. Long JR, Mitchell L Pulmonary aspergillosis in a mare. Can Vet J 1971, 12(1):16.
42. Rush-Moore B, Reed SM, Kowolski J, et al. Aspergillosis granuloma in the mediastinum of a non-immunocompromised horse. Cornell Vet 1993, 83:97.
43. Pirie RS, Dixon PM, McGorum BC Endotoxin contamination contributes to the pulmonary inflammatory and functional response to Aspergillus fumigatus extract inhalation in heaves horses. Clin Exp Allergy 2003, 33:1289.
44. Eder C, Crameri R, Mayer C, et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 2000, 73(3/4):241.
45. Schmallenbach KH, Rahman I, Sasse HH, et al. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998, 66:245.
46. Hare JE, Viel L, Conlon PD, et al. In vitro allergen-induced degranulation of pulmonary mast cells from horses with recurrent airway obstruction (heaves). Am J Vet Res 1999, 60(7):841.
47. Leguillette R Recurrent airway obstruction: heaves. Vet Clin North Am Equine Pract 2003, 19(1):63.
48. Davis E, Rush BR Equine recurrent airway obstruction: pathogenesis, diagnosis, and patient management. Vet Clin North Am Equine Pract 2002, 18(3):453.
49. Moore CP, Fales WH, Whittington P, et al. Bacterial and fungal isolates from Equidae with ulcerative keratitis. J Am Vet Med Assoc 1983, 182(6):600.
50. Moore CP, Collins BK, Fales WH, et al. Antimicrobial agents for treatment of infectious keratitis in horses. J Am Vet Med Assoc 1995, 207(7):855.
51. Brooks DE Inflammatory stromal keratopathies: medical management of stromal keratomalacia, stromal abscesses, eosinophilic keratitis, and band keratopathy in the horse. Vet Clin North Am Equine Pract 2004, 20:345.
52. Searl SS, Udell IJ, Sadun A, et al. Aspergillus keratitis with intraocular invasion. Ophthalmology 1981, 88:1244.
53. Grahn B, Wolfer J, Keller C, et al. Equine keratomycosis: clinical and laboratory findings in 23 cases. Prog Vet Comp Ophthalmol 1993, 3(1):2.
54. Kern TJ, Brooks DE, White MM Equine keratomycosis: current concepts of diagnosis and therapy. Equine Vet J Suppl 1983, 2:33.
55. Welch PM, Gabal M, Betts DM, et al. In vitro analysis of anti-angiogenic activity of fungi isolated from clinical cases of equine keratomycosis. Vet Ophthalmol 2000, 3:145.
56. Williams JH, Phillips TD, Jolly PE, et al. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 2004, 80:1106.
57. Robens JF, Richards JL Aflatoxins in animal and human health. Rev Environ Contam Toxicol 1992, 127:69.
58. Hamor RE, Welan NC Equine infectious keratitis. Clin Pharmacol Ther 1999, 15(3):623.
59. Barton MH Equine keratomycosis. Compend Equine Pract 1992, 14(7):936.
60. Beech J, Sweeney CR Keratomycosis in 11 horses. Equine Vet J Suppl 1983, 2:39.
61. Greet TRC Nasal aspergillosis in three horses. Vet Rec 1981, 109:487.
62. Tremaine WH, Dixon PM A long-term study of 277 cases of equine sinonasal disease. Part 1. Details of horses, historical, clinical and ancillary diagnostic findings. Part 2. Treatments and results of treatments. Equine Vet J 2001, 33(3):274. 283.
63. Nickels FA Diseases of the nasal cavity. Vet Clin North Am Equine Pract 1993, 9(1):111.
64. Hess MB, Parker NA, Purswell BJ, et al. Use of lufenuron as a treatment for fungal endometritis in four mares. J Am Vet Med Assoc 2002, 221(2):266.
65. Mahaffey LW, Adam NM Abortions associated with mycotic lesions of the placenta in mares. J Am Vet Med Assoc 1964, 144(1):24.
66. Bortell R, Asquith RL, Edds GT, et al. Acute experimentally induced aflatoxicosis in the weanling pony. Am J Vet Res 1983, 44(11):2110.
67. Vesonder R, Halibuton J, Stubblefield R, et al. Aspergillus flavus and aflatoxins B1, B2, and M1 in corn associated with equine death. Arch Environ Contam Toxicol 1991, 20(1):151.
68. Guillot J, Sarfati J, de Barros M, et al. Comparative study of serological tests for diagnosis of equine aspergillosis. Vet Rec 1999, 145(12):348.
69. Belknap EB, Barden CA, Yin C, et al: Real time PCR as a diagnostic tool for equine fungal keratitis: a preliminary study. In Proceedings of the 36th Annual ACVO Conference, Nashville, Tenn, 2005, p 26.
70. Willinger B Laboratory diagnosis and therapy of invasive fungal infections. Curr Drug Targets 2006, 7(4):513-522.
71. Hospenthal DR, Murray CK, Rinaldi MG The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 2004, 48:153.
72. Groll AH, Kolve H Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis 2004, 23:256.
73. Balkis MM, Leidich SD, Mukherjee PK, et al. Mechanisms of fungal resistance: an overview. Drugs 2002, 62(7):1025.
74. Groll AH, Walsh TJ Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly 2002, 132:303.
75. Rex JH, Pfaller MA Has antifungal susceptibility testing come of age?. Clin Infect Dis 2002, 35:982.
76. Latimer FG, Colitz CM, Campbell NB, et al. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. Am J Vet Res 2001, 62(10):1606.
77. Troke PF, Andrews RJ, Pye GW Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Rev Infect Dis 1990, 12(suppl 3):s276.
78. Pfaller MA, Sheehan DJ, Rex JH Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 2004, 17(2):268.
79. Brooks DE, Andrew SE, Strubbe DH, et al. Rose bengal positive epithelial microerosions as a manifestation of equine keratomycosis. Vet Ophthalmol 2000, 3(2/3):83.
80. Vanden Bossche H, Engelen M, Rochette F Antifungal agents of use in animal health: chemical, biochemical and pharmacological aspects. J Vet Pharmacol Ther 2003, 26:5.
81. Rochette F, Engelen M, Vanden Bossche H Antifungal agents of use in animal health: practical applications. J Vet Pharmacol Ther 2003, 26:31.
82. Stewart J Antifungal therapy for horses. Compend Contin Educ Pract Vet 2005, 27(11):871.
83. Pyle RL Clinical pharmacology of amphotericin B. J Am Vet Med Assoc 1981, 179(1):83.
84. Maertens JA, Boogaerts MA Fungal cell wall inhibitors: emphasis on clinical aspects. Curr Pharm Design 2000, 6:225.
85. Brajtburg J, Powderly WG, Kobayashi GS, et al. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 1990, 34(2):183.
86. Reilly LK: Systemic antifungal therapy in horses. In Proceedings of the 17th Annual Veterinary Forum, American College of Veterinary Internal Medicine, Chicago, 1999, p 214.
87. Reilly LK, Palmer JE Systemic candidiasis in four foals. J Am Vet Med Assoc 1994, 205:464.
88. Madison JB, Reid BV, Raskin RE Amphotericin B treatment of Candida arthritis in two horses. J Am Vet Med Assoc 1995, 206:338.
89. Ruoff WW Fungal pneumonia in horses. Proc Am Assoc Equine Pract 1989, 34:423.
90. McMullan WC, Joyce JR, Hanselka DV, et al. Amphotericin B for the treatment of localized subcutaneous phycomycosis in the horse. J Am Vet Med Assoc 1977, 170:1293.
91. Joyce JR, McMuan WC, Burns SJ The use of amphotericin B in late pregnancy in mares. J Equine Med Surg 1977, 1:256.
92. Riley CB, Yovich JV, Robertson JP, et al. Fungal arthritis due to infection by Candida famata in a horse. Aust Vet J 1992, 69:65.
93. Begg LM, Hughes KJ, Kessell A, et al. Successful treatment of cryptococcal pneumonia in a pony mare. Aust Vet J 2004, 82:686.
94. Cornick JL Diagnosis and treatment of pulmonary histoplasmosis in a horse. Cornell Vet 1990, 80:97.
95. Steckel RR, Adams SB, Long GG, et al. Antemortem diagnosis and treatment of cryptococcal meningitis in a horse. J Am Vet Med Assoc 1982, 180:1085.
96. Ellis D Amphotericin B; spectrum and resistance. J Antimicrob Agents Chemother 2002, 49(suppl 1):7.
97. Willinger B Laboratory diagnosis and therapy of invasive fungal infections. Curr Drug Targets 2006, 7(4):513.
98. Dupont B Overview of lipid formulations of amphotericin B. J Antimicrob Chemother 2002, 49(suppl 1):31.
99. Gaboriau F, Cheron M, Petit C, et al. Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrob Agents Chemother 1997, 41(11):2345.
100. Petit C, Cheron M, Joly V, et al. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating. J Antimicrob Chemother 1998, 42:779.
101. Bartlett K, Yau E, Hartsel SC, et al. Effect of heat-treated amphotericin B on renal and fungal cytotoxicity. Antimicrob Agents Chemother 2004, 48(1):333.
102. Shaker-Nejad K, Stahlmann R Drug interactions during therapy with three major groups of antimicrobial agents. Exper Opin Pharmacother 2006, 7(6):639-651.
103. Herbrecht R, Nivoix Y, Fohrer C Management of systemic fungal infections: alternatives to itraconazole. J Antimicrob Chemother 2005, 56(suppl 1):39.
104. Thomas PA Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003, 16(4):730.
105. Davis PR, Meyer GA, Hanson R, et al. Pseudallescheria boydii infection of the nasal cavity of a horse. J Am Vet Med Assoc 2000, 5(1):707.
106. Nappert G, Van Dyck T, Papich M, et al. Successful treatment of a fever associated with consistent pulmonary isolation of Scopulariopsis sp in a mare. Equine Vet J 1996, 28:421.
107. Prades M, Brown MP, Gronwall R, et al. Body fluid and endometrial concentrations of ketoconazole in mares after intravenous injection or repeated gavage. Equine Vet J 1989, 21(3):211.
108. Ziemer EL, Pappagianis D, Madigan JE Coccidioidomycosis in horses: 15 cases (1975-1984). J Am Vet Med Assoc 1992, 201:910.
109. Korenek NL, Legendre AM, Andrews FM, et al. Treatment of mycotic rhinitis with itraconazole in 3 horses. J Vet Intern Med 1994, 8:224.
110. Davis EW, Legendre AM Successful treatment of guttural pouch mycosis with itraconazole and topical enilconazole in a horse. J Vet Intern Med 1994, 8:304.
111. Foley JP, Legendre AM Treatment of coccidioidomycosis osteomyelitis with itraconazole in a horse. J Vet Intern Med 1992, 6:333.
112. Van Nieuwstadt RA, Kalsbeek HC Luchtzakmycose: locale behandleing via een permanente catheter met enilconazol. Tidschrift Voor Diergeneeskunde 1994, 119:3.
113. Latimer GB, Colitz CMH, Campbell NB, et al. Pharmacokinetics of fluconazole following intravenous and oral administration, and ocular tissue and body fluid concentrations of fluconazole following repeated oral dosing in horses. Vet Opthalmol 2001, 4:289.
114. Hendrix DVH, Ward DA, Guglick MA Disseminated candidiasis in a neonatal foal with keratomycosis as the initial sign. Vet Comp Ophthalmol 1997, 7:10.
115. Steinbach WJ, Stevens DA Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003, 37(suppl 3):157.
116. Clode AB, Davis J, Salmon J, et al: Aqueous humor concentrations of voriconazole after topical and oral administration in horses. In Proceedings of the 36th Annual ACVO Conference, Nashville, Tenn, 2005, p 31.
117. Clode AB, Davis JL, Salmon J, et al. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. AJVR 2006, 67(2):296.
118. Colitz CMH: Personal communication, Ohio State University, January 2006.
119. Grooters AM: New directions in antifungal therapy. In Proceedings of the 17th Annual Veterinary Forum, American College of Veterinary Internal Medicine, Chicago, 1999, p 637.
120. Scotty NC, Evans TJ, Giuliano E, et al. In vitro efficacy of lufenuron against filamentous fungi and blood concentrations after PO administration in horses. J Vet Intern Med 2005, 19:878.
121. Li RK, Rinaldi MG In vitro antifungal activity of nikkomycin Z in combination with fluconazole and itraconazole. Antimicrob Agents Chemother 1999, 43(6):1401.
122. Ball MA, Rebhun WC, Gaarder JE, et al. Evaluation of itraconazole-dimethyl sulfoxide ointment for treatment of keratomycosis in nine horses. J Am Vet Med Assoc 1997, 211(2):199.
123. Foster CS, Lass JH, Moran-Wallace K, et al. Ocular toxicity of topical antifungal agents. Arch Ophthalmol 1981, 99(6):1081.
124. Bistner SI, Riis RC Clinical aspects of mycotic keratitis in the horse. Cornell Vet 1979, 69:364.
125. Foster CS, Stefanyszyn M Intraocular penetration of miconazole in rabbits. Arch Ophthalmol 1979, 97:1703.
126. Ball MA, Rebhun WC, Trepanier L, et al. Corneal concentrations and preliminary toxicological evaluation of an itraconazole/dimethyl sulphoxide ophthalmic ointment. J Vet Pharmacol Ther 1997, 20:100.
127. Brayton CF Dimethyl Sulfoxide (DMSO): a review. Cornell Vet 1986, 76(1):61-90.
128. Landsdown AB A review of the use of silver in wound care: facts and fallacies. Br J Nurs 2004, 13(6 suppl):S6.
129. Mohan M, Gupta VK, Kalra RB, et al. Topical silver sulphadiazine: a new drug for ocular keratomycosis. Br J Ophthalmol 1988, 72:192.
130. Vanden Bossche H, Engelen M, Rochette F Antifungal agents of use in animal health-chemical, biochemical and pharmacological aspects. J Vet Phramacol Ther 2003, 26(1):5-29.
131. Joyce JR Thiabendazole therapy of mycotic keratitis in horses. Equine Vet J Suppl 1983, 2:45.
132. Pascoe RR Experimental medication of equine ringworm due to Trichophyton equinum var. autotrophicum. Aust Vet J 1984, 61:231.
133. Brooks DE, Andrew SE, Naisse MP Comments regarding retrospective study on horses with fungal keratitis. JAVMA 1998, 218(5):603. (letter to the editor).
134. Hendrix DVH, Brooks DE, Smith PJ, et al. Corneal stromal abscesses in the horse: a review of 24 cases. Equine Vet J 1995, 27(6):440.
135. Steinbach WJ Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies. Curr Drug Targets Infect Disord 2005, 5(3):203.
136. French DD, Haynes PF, Miller RI, et al. Surgical and medical management of rhinophycomycosis (conidiobolomycosis) in a horse. J Am Vet Med Assoc 1985, 186:1105.
137. Carmalt JL, Baptiste KE Atypical guttural pouch mycosis in three horses. Pferdeheikunde 2004, 20(6):542.